Novacyt S.A.
EPA:ALNOV.PA
0.879 (EUR) • At close September 18, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) EUR.
| 2023 Q4 | 2023 Q2 | 2023 Q1 | 2022 Q4 | 2022 Q3 | 2022 Q2 | 2021 Q4 | 2021 Q2 | 2020 Q2 | 2019 Q4 | 2019 Q2 | 2018 Q4 | 2018 Q2 | 2017 Q4 | 2016 Q4 | 2015 Q2 | 2014 Q2 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 9.545 | 1.943 | 1.899 | 2.558 | 2.582 | 19.59 | 49.112 | 62.173 | 72.374 | 5.858 | 7.223 | 6.677 | 0 | 0 | 0 | 0 | 0 |
| Cost of Revenue
| 10.623 | 0.974 | 0.952 | 1.787 | 1.804 | 16.067 | 25.09 | 19.411 | 13.006 | 3.015 | 3.506 | 3.408 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit
| -1.077 | 0.969 | 0.947 | 0.771 | 0.778 | 3.523 | 24.022 | 42.762 | 59.368 | 2.843 | 3.717 | 3.269 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit Ratio
| -0.113 | 0.499 | 0.499 | 0.301 | 0.301 | 0.18 | 0.489 | 0.688 | 0.82 | 0.485 | 0.515 | 0.49 | 0 | 0 | 0 | 0 | 0 |
| Reseach & Development Expenses
| 2.304 | 0.721 | 0.705 | 1.003 | 1.012 | 3.882 | 3.445 | 2.168 | 0.593 | 0.222 | 0.229 | 0.119 | 0 | 0 | 0 | 0 | 0 |
| General & Administrative Expenses
| 0 | 3.246 | 3.173 | 2.84 | 2.867 | 3.608 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 0 | 0.876 | 0.856 | 1.095 | 1.105 | 1.677 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 9.724 | 4.123 | 4.029 | 4.204 | 4.244 | 9.561 | 5.606 | 15.213 | 10.104 | 3.261 | 4.093 | 2.222 | 0 | 0 | 0 | 0 | 0 |
| Other Expenses
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Operating Expenses
| 12.028 | 5.795 | 5.663 | 8.004 | 8.08 | 13.443 | 9.051 | 17.381 | 10.697 | 3.483 | 4.322 | 2.341 | 0 | 0 | 0 | 0 | 0 |
| Operating Income
| -13.105 | -3.81 | -3.723 | -4.222 | -4.262 | -9.92 | 14.971 | 25.381 | 48.671 | -0.64 | -0.605 | 0.928 | 0 | 0 | 0 | 0 | 0 |
| Operating Income Ratio
| -1.373 | -1.961 | -1.961 | -1.65 | -1.65 | -0.506 | 0.305 | 0.408 | 0.672 | -0.109 | -0.084 | 0.139 | 0 | 0 | 0 | 0 | 0 |
| Total Other Income Expenses Net
| -10.359 | -1.028 | -1.004 | -3.098 | -3.128 | 1.513 | -8.734 | -42.83 | -2.551 | -2.062 | -0.603 | -1.164 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax
| -23.464 | -4.837 | -4.727 | -7.321 | -7.39 | -8.407 | 6.237 | -17.449 | 46.12 | -2.702 | -1.208 | -0.236 | 0 | 0 | 0 | 0 | 0 |
| Income Before Tax Ratio
| -2.458 | -2.49 | -2.49 | -2.862 | -2.862 | -0.429 | 0.127 | -0.281 | 0.637 | -0.461 | -0.167 | -0.035 | 0 | 0 | 0 | 0 | 0 |
| Income Tax Expense
| -0.688 | 0.101 | 0.099 | 2.365 | 2.387 | -2.422 | 2.777 | -2.842 | 5.925 | -0.008 | 0.786 | 0.032 | 0 | 0 | 0 | 0 | 0 |
| Net Income
| -23.104 | -4.736 | -4.628 | -9.685 | -9.777 | -10.323 | 3.46 | -14.607 | 40.195 | -4.564 | -1.994 | -2.894 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio
| -2.42 | -2.438 | -2.438 | -3.786 | -3.786 | -0.527 | 0.07 | -0.235 | 0.555 | -0.779 | -0.276 | -0.433 | 0 | 0 | 0 | 0 | 0 |
| EPS
| -0.33 | -0.07 | -0.068 | -0.14 | -0.14 | -0.15 | 0.049 | -0.21 | 0.61 | -0.091 | -0.053 | -0.077 | 0 | 0 | 0 | 0 | 0 |
| EPS Diluted
| -0.33 | -0.067 | -0.066 | -0.14 | -0.14 | -0.15 | 0.049 | -0.21 | 0.61 | -0.091 | -0.053 | -0.077 | 0 | 0 | 0 | 0 | 0 |
| EBITDA
| -9.636 | -3.299 | -3.224 | -3.568 | -3.304 | -8.684 | 23.123 | 26.462 | 49.568 | 0.309 | 0.258 | 1.772 | 0 | 0 | 0 | 0 | 0 |
| EBITDA Ratio
| -1.009 | -1.698 | -1.698 | -1.395 | -1.28 | -0.443 | 0.471 | 0.426 | 0.685 | 0.053 | 0.036 | 0.265 | 0 | 0 | 0 | 0 | 0 |